FDA approves SAGE Therapeutics' (SAGE) treatment for post-partum depression

March 19, 2019 5:39 PM
The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot FDA News